AtriCure (ATRC) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $44.30 +1.86%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q4 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $73.2 million versus the consensus estimate of $72.39 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
